(Q33929832)

English

A current perspective on leishmaniasis

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20606967

retrieved

30 July 2017

title

A current perspective on leishmaniasis (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

30 July 2017

Angela Clem

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20606967

retrieved

30 July 2017

language of work or name

English

0 references

publication date

1 May 2010

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20606967

retrieved

30 July 2017

published in

Journal of Global Infectious Diseases

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20606967

retrieved

30 July 2017

volume

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20606967

retrieved

30 July 2017

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20606967

retrieved

30 July 2017

page(s)

124-126

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20606967

retrieved

30 July 2017

cites work

Novel arylimidamides for treatment of visceral leishmaniasis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2889651

retrieved

5 July 2018

Amiodarone and miltefosine act synergistically against Leishmania mexicana and can induce parasitological cure in a murine model of cutaneous leishmaniasis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2889651

retrieved

5 July 2018

The antituberculosis drug pyrazinamide affects the course of cutaneous leishmaniasis in vivo and increases activation of macrophages and dendritic cells.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2889651

retrieved

5 July 2018

Cellular and humoral responses to Leishmania major virulence factors in healed cutaneous leishmaniasis and Mediterranean visceral leishmaniasis patients

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2889651

retrieved

29 October 2018

Designing therapies against experimental visceral leishmaniasis by modulating the membrane fluidity of antigen-presenting cells

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2889651

retrieved

29 October 2018

Identifiers

DOI

10.4103/0974-777X.62863

1 reference

stated in

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

20606967

retrieved

30 July 2017

PubMed publication ID

20606967

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20606967

retrieved

30 July 2017

(Q33929832)

A current perspective on leishmaniasis

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)